VIP

Human evidence for VIP is limited — pilot studies, withdrawn trials, or completed trials without posted results. Off-label / exploratory data exists for 10 additional indications (Pharmacokinetic / healthy volunteer studies; Covid19).

VIP

Research Evidence

Evidence shape

Human evidence for VIP is limited — pilot studies, withdrawn trials, or completed trials without posted results. Off-label / exploratory data exists for 10 additional indications (Pharmacokinetic / healthy volunteer studies; Covid19).

Depthhow much
11 registered trials
10 completed · 1 recruiting / active
Breadthhow many areas
11 indications mapped
10 thin / exploratory · 1 animal-only · 9 single-trial long-tail
Qualityhow rigorous
Highest tier: Phase 3
7 distinct sponsors · 4 linked publications on registered trials
Breadth and depth35 rows captured
Human
direct clinical signal
11
Animal
translational support
12
In vitro
mechanistic support
12
HighMediumLow

Anecdotal efficacy

Price

1
US
10 mg
$0.99
$0.099/mg
2
--
10 mg
$31.45
$3.15/mg
3
US
10 mg
$38.00
$3.8/mg
4
US
100 mg
$439.99
$4.4/mg
5
US
10 mg
$45.00
$4.5/mg
6
US
100 mg
$458.00
$4.58/mg

price offers can be sorted by column

1-6 of 59

Dosing & Protocol

How VIP is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.

Research trials
Published clinical-trial protocols · n = 10
Typical dose
No quantified dose captured for this tier.
Frequency
unspecified
Timing
unspecified
Route
unspecified
Cycle
unspecified

10 completed trials identified; trial dosing not reliably extracted from registry data.

8 sources
Clinician practice
Doctor & published-protocol guidance · n = 2
Typical dose
200 µg
200 µg
200 µg
Frequency
daily
Timing
unspecified
Route
subQ
Cycle
unspecified

Clinician protocols dose 200 µg daily subQ (2 sources).

2 sources
Anecdotal
Community-reported real-world use · n = 6
Typical dose
No quantified dose captured for this tier.
Frequency
unspecified
Timing
unspecified
Route
unspecified
Cycle
unspecified

Anecdotal reports involving VIP are positive regarding its use for inflammatory conditions (3 of 3 reports) and neuroprotection/headache relief (2 of 3 reports positive). However, specific dosing information from community posts is not available.

Peptide Deep Dive

Peptide Deep Dive is not projected for this peptide yet.

Regulatory safety notes

Warnings and precautions
  • WARNINGS: Consult a physician for use in children under 12 years of age. IF PREGNANT OR BREASTFEEDING, ask a health care professional before use. In case of overdose (or accidental ingestion) get medical help or contact a Poison Control Center right away. KEE…

Peptide feedback

0 forum replies

Live community discussion for VIP, shown here in the site layout and continued on the TVR forum.

Add feedback

No peptide feedback yet

Start the peptide feedback thread on the TVR forum.